About Us

Arcomedlab was founded in 2018 with the purpose of connecting patients to first-class health technologies, thereby improving their quality of life.

Our distinctive seal is a powerful R&D area: reasearch and development focused on  personalized medicine.

Implants put in place successfully throughout the world

Countries in which arcomedlab implants are available

Milestones:

  • Awarded Best Startup of the year 2022 by El Mercurio newspaper.
  • Winner of the Ganesha Lab 7th Generation of Startups, year 2022.
  • Patent pending in 22 countries for drug releasing implants (DRS)
  • Prize awarded by the Everis Foundation for outstanding performance in its Innovation Contest held in Spain and Chile amongst 70 participants.
  • Certified by the Instituto de Salud Pública de Chile (ISP).
  • Certified for compliance with the international standard ISO 13485; certification by the FDA pending.
  • Filing of a utility model to improve temporomandibular joint implants.
  • Acquisition of a patent to design and manufacture synthetic bone implants by a 3D printing process.
  • Awarded a “Consolida y Expande” grant by CORFO to support the internationalization of arcomedlab, year 2022.